Abstract
Highly active antiretroviral therapy is not sufficient to fully control HIV replication and problems of side effects and escape mutation have emerged. Current prophylactic and therapeutic vaccine strategies appear to be unable to confer full protection. However, given the rapid recent progress made in RNA interference and lentivirus technologies, it may soon be possible to develop effective gene therapies against HIV infection. We describe here the recent progress made in the lentivirus-based HIV-1-targeting RNAi system and the possibility that this system can be used to generate an anti-HIV-1 gene therapy. We speculate that this system would be most useful if it would be used in a coordinated manner with vaccines that can initiate and maintain potent anti-HIV immunity.
Keywords: RNAi, lentivirus vector, gene therapy, HIV infection, vaccines
Current Gene Therapy
Title: Prospects for the Therapeutic Application of Lentivirus-Based Gene Therapy to HIV-1 Infection
Volume: 8 Issue: 1
Author(s): Takuya Yamamoto and Yasuko Tsunetsugu-Yokota
Affiliation:
Keywords: RNAi, lentivirus vector, gene therapy, HIV infection, vaccines
Abstract: Highly active antiretroviral therapy is not sufficient to fully control HIV replication and problems of side effects and escape mutation have emerged. Current prophylactic and therapeutic vaccine strategies appear to be unable to confer full protection. However, given the rapid recent progress made in RNA interference and lentivirus technologies, it may soon be possible to develop effective gene therapies against HIV infection. We describe here the recent progress made in the lentivirus-based HIV-1-targeting RNAi system and the possibility that this system can be used to generate an anti-HIV-1 gene therapy. We speculate that this system would be most useful if it would be used in a coordinated manner with vaccines that can initiate and maintain potent anti-HIV immunity.
Export Options
About this article
Cite this article as:
Yamamoto Takuya and Tsunetsugu-Yokota Yasuko, Prospects for the Therapeutic Application of Lentivirus-Based Gene Therapy to HIV-1 Infection, Current Gene Therapy 2008; 8 (1) . https://dx.doi.org/10.2174/156652308783688536
DOI https://dx.doi.org/10.2174/156652308783688536 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Nanoporous Silica of Some Egyptian Diatom Frustules as a Promising Natural Material
Nanoscience & Nanotechnology-Asia The Use of Nitric Oxide Synthase Inhibitors in Inflammatory Diseases: A Novel Class of Anti-Inflammatory Agents
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents ERRATUM
Current Alzheimer Research Computational Approaches for the Identification and Optimization of Src Family Kinases Inhibitors
Current Medicinal Chemistry Mitochondrial Dysfunction in Depression
Current Neuropharmacology Pleasure as an Overlooked Target of Substance Use Disorder Research and Treatment
Current Drug Abuse Reviews MicroRNA Therapeutics in Neurological Disease
Current Pharmaceutical Design Antipsychotic Medication: The Potential Role of 5-HT1A Receptor Agonism
Current Pharmaceutical Design Age Related Macular Degeneration and Visual Disability
Current Drug Targets The Endocannabinoid System and Multiple Sclerosis
Current Pharmaceutical Design The Use of Cell Products for Treatment of Autoimmune Neuroinflammatory Diseases
Current Medicinal Chemistry Recent Advances in Progressive Supranuclear Palsy: A Review
Current Alzheimer Research Collecting Information for Rating Global Assessment of Functioning (GAF): Sources of Information and Methods for Information Collection
Current Psychiatry Reviews An Experimental Model for Exudative Age-related Macular Degeneration with Choroidal Neovascularization Using the Common Marmoset
Current Neurovascular Research Editorial: [The “Hair of the Dog”: A Useful Hangover Remedy or a Predictor of Future Problem Drinking?]
Current Drug Abuse Reviews Treatment Related Morbidity in Cervical Cancer
Current Women`s Health Reviews Recent Patents Concerning Targeted Therapy of Apoptosis Resistance in Pancreatic Cancer
Recent Patents on DNA & Gene Sequences Converging Perturbed Microvasculature and Microglial Clusters Characterize Alzheimer Disease Brain
Current Alzheimer Research Modulation of Protein-Protein Interactions as a Therapeutic Strategy for the Treatment of Neurodegenerative Tauopathies
Current Topics in Medicinal Chemistry Endocannabinoids in Appetite Control and the Treatment of Obesity
CNS & Neurological Disorders - Drug Targets